Murphy, Middleton, Hinkle & Parker »

Crispr Therapeutics shares owned by Murphy, Middleton, Hinkle & Parker

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Murphy, Middleton, Hinkle & Parker from 13F filings

Historical chart of Murphy, Middleton, Hinkle & Parker investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Murphy, Middleton, Hinkle & Parker consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Murphy, Middleton, Hinkle & Parker

Quarter filed Position value Share count Share price at filing
2025-12-31 $598k 906 660.40

More positions owned by Murphy, Middleton, Hinkle & Parker

PPG Industries (PPG)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Exchange Traded Fd T Water Res Etf (PHO)
Carnival Corp Unit 99/99/9999 (CCL)
Baxter International (BAX)
Bank of New York Mellon Corporation (BK)
Home Depot (HD)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Prudential Financial (PRU)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Procter & Gamble Company (PG)
Oshkosh Corporation (OSK)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Ishares Silver Tr Ishares (SLV)

View all positions for Murphy, Middleton, Hinkle & Parker

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics